Augmentation of mouse natural killer cell activity by combined hyperthermia and streptococcal preparation, OK-432 (Picibanil) treatment

References

• Fujii M., Abo T., Kumagai K. Cytokines produced by blood mononuclear cells stimulated with the streptococcal preparation OK-432: effect on production by supplementing the medium with xenogenic serum. Cancer Immunology and Immunotherapy 1988; 27: 97–102
   PubMed Web of Science ®Google Scholar
• Fukui H., Reynolds C. V., Lenz B., Schneider M., Talmadge J. E. Mechanism of immunotherapeutic activity of OK-432 in the treatment of peritoneal carcinomatosis. Cancer Immunology and Immunotherapy 1989; 29: 1–6
   PubMed Web of Science ®Google Scholar
• Habu S., Fukui I., Shimamura K., Kasai M., Nagai Y., Okumura K., Tamaoki N. In vivo effects of anti-asialo GM1 I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. Journal of Immunology 1981; 127: 34–38
   PubMed Web of Science ®Google Scholar
• Hochman P. S., Cudkowicz G., Dausset J. Decline of natural killer cell activity in sublethally irradiated mice. Journal of the National Cancer Institute 1978; 61: 265–268
   PubMed Web of Science ®Google Scholar
• Ishida N., Hoshino T. A streptococcal preparation as a potent biological response modifier, OK-432. Excerpta Medica. 1985
   Google Scholar
• Ishii Y., Yamaoka H., Toh K., Kikuchi K. Inhibition of tumor growth in vivo and in vitro by macrophages from rats treated with a streptococcal preparation, OK-432. Gann 1976; 67: 115–119
   PubMedGoogle Scholar
• Kawaguchi T., Suematsu H., Koizumi M., Mitsui H., Suzuki S., Matsuno T., Ogawa H., Nomoto K. Activation of macrophage function by intraperitoneal administration of the streptococcal antitumor agent OK-432. Immunopharmeicology 1983; 6: 177–189
   PubMed Web of Science ®Google Scholar
• Kimura I., Ohnoshi Y., Yasuhara S., Watanabe T., Sugiyama M., Kiraki K. Studies on the host-mediated action of the streptococcal preparation, OK-432, in cancer chemotherapy. Acta Medica Okayama 1974; 28: 423–431
   PubMed Web of Science ®Google Scholar
• Nakano H. Studies on absorption. distribution, metabolism and excretion of streptococcal anticancer agent OK-432 in tumor-bearing mice. Proceedings of the 3rd Symposium on Drug Metaholism and Action, FukuokaJapan. Nanzando, Tokyo 1971; 111–137, (in Japanese)
   Google Scholar
• Okamoto H., Shoin S., Koshimura A., Shimizu R. Studies on the anticancer and streptolysin S-forming abilities of hemolytic streptococci. Japunese Journal of Microbiology 1967; 11: 323–336
   PubMedGoogle Scholar
• Oshimi K., Wakasugi H., Seki H., Kano S. Streptococcal preparation OK-432 augments cytotoxic activity against an erythroleukemic cell line in humans. Cancer Immunology and Immunotherapy 1980b; 9: 187–192
   Web of Science ®Google Scholar
• Oshiml K., Kano S., Takaku F., Okumura K. Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432. Journal of the National Cancer Institute 1980a; 65: 1265–1269
   PubMedGoogle Scholar
• Riccardi C., Barlozzari T., Santoni A., Herberman R. B., Cesarini C. Transfer to cyclophosphamide-treated mice of natural killer (NK) cells and in vivo natural reactivity against tumors. Journal of Immunology 1981; 126: 1284–1289
   PubMed Web of Science ®Google Scholar
• Ryoyama C., Ryoyama K. Effects of injection routes of growing tumors PSK or OK-432 on antiproliferative activity of mouse serum. Cancer Immunology and Immunotherapy 1989; 28: 101–106
   PubMed Web of Science ®Google Scholar
• Saiio M., Nanjo M., Aonuma E., Noda T., Nakadate I., Ebina T., Ishida N. Activated macrophages are responsible for the tumor-inhibitory effect in mice receiving intravenous injection of OK-432. Internarional Journal of Cancer 1984; 33: 271–276
   PubMed Web of Science ®Google Scholar
• Sakurai Y., Tsukagoshi S., Sato H., Akiba T., Suzuki S., Takagaki Y. Tumor-inhibitory effect of a streptococcal preparation (NCS-B116209). Cancer Chemotherapy Repoils 1972; 56: 9–17
   PubMedGoogle Scholar
• Sato M., Kaji R., Urata M., Yoshida H., Yanagawa T., Miyamoto, Azuma M., Furumuro N., Saito M. Monoclonal antibody to the streptococcal preparation OK-432: tissue OK-432 localization and analysis of interaction between OK-432 and inacrophages or NK cells in human salivary adenocarcinoma-bearing nude mice given OK-432. Journal of Biological Response Modifiers 1988; 7: 212–228
   PubMedGoogle Scholar
• Tomasovic S. P., Barta M., Klostergaard J. Temporal dependence of hyperthermic augmentation of macrophage-TNF production and tumor cell-TNF sensitization. International Journal of Hyperthermia 1989; 5: 625–639
   PubMed Web of Science ®Google Scholar
• Urano M. Tumor response to hyperthermia. Hyperthermia and Oncology, M. Urano, E. Douple. VSP, Utrecht 1988; Vol. 1: 161–200
   Google Scholar
• Urano M., Nesumi N., Ando K., Koike S., Ohnuma N. Repair of potentially lethal radiation damage in acute and chronically hypoxic tumor cells in vivo. Radiology 1976; 118: 147–451
   PubMed Web of Science ®Google Scholar
• Urano M., Overgaard M., Sulr H. D., Dunn P., Sedlacek R. Enhancement hy Corynebacterium parvum of the normal and tumor tissue response to hyperthermia. Cancer Research 1978; 38: 862–864
   PubMed Web of Science ®Google Scholar
• Urano M., Rice L., Epstein R., Suit H. D., Chu A. M. Effect of whole-body hyperthermia on cell survival, metastasis frequency and host immunity in moderately and weakly immunogenic murine tumors. Cancer Research 1983; 43: 1039–1043
   PubMed Web of Science ®Google Scholar
• Urano M., Surr H. D., Dunn P., Lansdale T., Sedlacek R. Enhancement of the thermal response of animal tumors by. C. parvum. Cancer Rescarch 1979; 39: 3454–3457
   PubMed Web of Science ®Google Scholar
• Urano M., Taradi M., Taradi S. K. Enhancement of thermal response of murine tumor and normal tissue by streptococcal preparation OK-432 (Picibanil). International Journal of Hyperthermia 1991; 7: 113–123
   PubMed Web of Science ®Google Scholar
• Urano M., Yamashita T., Suit H. D., Gerweck L. E. Enhancement of thermal response of normal and malignant tissues by. Coynebacterium parvum. Cancer Research 1984; 44: 2341–2347
   PubMed Web of Science ®Google Scholar
• Urano M., Gerweck L. E., Epstein R., Cunningham M., Suit H. D. Response of spontaneous murine tumor to hyperthermia: factors which modify the thermal response. in vivo. Radiation Research 1980; 83: 312–322
   PubMed Web of Science ®Google Scholar
• Yamamoto A., Nagamuta M., Usami H., Sugawara Y., Watanabe N., Niitsu Y., Urushizaki I. Release of tumor necrosis factor (TNF) into mouse peritoneal fluids by OK-432, a streptococcal preparation. Immunopharmacology 1986; 11: 79–86
   PubMed Web of Science ®Google Scholar